CHICAGO — Individuals with traumatic brain injury (TBI) continue to pay a significant economic price years after their injury, new observational data suggested. In a large […]

Preliminary 6-month results from the first-in-human trial of deep brain stimulation (DBS) of the subgenual singulate cortex (SCC) for chronic low back pain, suggested that the […]

The bolus thrombolytic agent, tenecteplase, narrowly failed to show non-inferiority to alteplase in the TASTE clinical trial within 4.5 hours of symptom onset selected by perfusion […]

New expert guidance to help clinicians manage the treatment of patients with epilepsy during pregnancy has been released. Issued by the American Academy of Neurology, the […]

The full results of the ANNEXA-I trial have continued to show mixed effects of the factor Xa inhibitor reversal agent, andexanet (Andexxa/Ondexxya, AstraZeneca), in patients with […]

Meningitis has been highlighted as a novel risk factor for trigeminal neuralgia (TN) in a nationwide, propensity-matched study of hospital admissions. In multivariate analysis, the odds […]

CHICAGO — The diabetes/weight loss drug semaglutide is associated with a significantly greater risk for repeat operations in patients with diabetes who require lumbar surgery, a […]

CHICAGO — Early results from a first-in-human trial some 20 years in the making suggest that neural stem cell transplantation is safe and improves motor function […]

There is no association between the SARS-CoV-2 vaccine and the risk for new-onset seizure, data from a new meta-analysis of six randomized, placebo-controlled clinical trials (RCTs) […]